Diabetes, Type 2 Clinical Trial
Official title:
A Long-term Clinical Study of OPC-262 in Patients With Type 2 Diabetes on Study (Extension From Study 262-09-001)
The purpose of this clinical study is to evaluate the safety of OPC-262 (2.5 mg and 5 mg) in patients with type 2 diabetes by long-term administration orally for 52 weeks and to evaluate the efficacy of OPC-262
n/a
Endpoint Classification: Safety/Efficacy Study, Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Treatment
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT01805414 -
Breakfast Nutrition and Inpatient Glycemia
|
N/A | |
| Completed |
NCT01427660 -
iDecide.Decido: Diabetes Medication Decision Support Study
|
N/A | |
| Completed |
NCT02648685 -
The Study to Investigate the Contribution of Basal and Postprandial Glucose to Overall Hyperglycemia in T2DM
|
||
| Completed |
NCT00141232 -
Evaluating Atorvastatin With Omega-3 Fatty Acids in Cardiovascular Risk Reduction in Patients With Type 2 Diabetes
|
Phase 4 | |
| Completed |
NCT03397225 -
A Lifestyle Intervention for Type 2 Diabetes Patients in Kuwait and Its Impact on Glycaemic Control
|
N/A | |
| Completed |
NCT01837680 -
Glycemic Control Using Insulin Levemir Versus Insulin NPH for Diabetes in Pregnancy
|
N/A | |
| Completed |
NCT01336738 -
Study Of Safety And Efficacy Of PF-04991532 In Subjects With Type 2 Diabetes Mellitus
|
Phase 2 | |
| Completed |
NCT00308737 -
Safety of Inhaled Insulin With Type 1 and Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT00246987 -
A Trial to Evaluate BMS-298585 as Monotherapy in Subjects With Type 2 Diabetes Who Have Inadequate Glycemic Control
|
Phase 3 | |
| Completed |
NCT01193179 -
A Phase 3 Study of OPC-262 in Patients With Type 2 Diabetes
|
Phase 3 | |
| Completed |
NCT00857558 -
A Phase 2 Study of OPC-262 in Patients With Type 2 Diabetes
|
Phase 2 | |
| Terminated |
NCT01350102 -
The Relationship of Hemoglobin A1c and Diabetic Wound Healing
|
Phase 4 | |
| Completed |
NCT01624116 -
Comparison of Hypoglycaemic Regimens During Ramadan Fasting in Type 2 Diabetes
|
N/A | |
| Withdrawn |
NCT02222623 -
The Inova Type 2 Diabetes Mellitus Study
|
N/A | |
| Recruiting |
NCT06340854 -
A Research Study to See How Switching From a Daily Basal Insulin to a New Weekly Insulin, Insulin Icodec, Helps in Reducing the Blood Sugar Compared to Daily Insulin Glargine in Adults With Type 2 Diabetes
|
Phase 3 |